Özge Akbulut-Çalışkan

[Özge Akbulut-Çalışkan @ozgeakblt]

Publication alert 🪇
Here, you can access our latest review article on a key target in cancer research. Now, online in #ClinicalandTranslationalOncology. Enjoy ✨️

#cancer #HER2targetedtherapy #colorectalcancer #springernature
@SpringerNature
https://t.co/QJK2G5Y67m

[Caydasi Lab - Cell Cycle & Signaling @CaydasiLab]

Support Ahmed Alsaftawi, an exceptional PhD student in my lab @KocUniversity, as he raises funds to help his family in Gaza. Despite his fear every day, @AhmedSaftawi continues to inspire me with his dedication to cell biology. Please, spread the word. https://t.co/iXxDqgWwO2

[OzgurSahinLab @OzgurSahinLab]

Our new paper on overcoming resistance to the iconic antibody-drug conjugate, T-DM1 in HER2+ breast cancer has been published in Cancer Research!

https://t.co/3xAWX5K0ch

[Gokhan Demirel @gokhandemirels]

Hybrid education 😡😡😡

[Arda Secme @ArdaSecme]

Our paper has been published in IEEE Sensors
https://t.co/SjMDemyCbc

Herein, we combined optical imaging (left) and microwave detection (right) to differentiate microscale analytes based on their dielectric properties.
In the video, MDA-MB-231 cancer cell is measured over time:

[OzgurSahinLab @OzgurSahinLab]

Our latest article is online now! Please check it out!

https://t.co/anC0bPtJ0Q

[EACR @EACRnews]

Our Board has agreed new initiatives to support EACR members in Turkey and Syria, offering them:
👉Free registration to our next two virtual conferences.
👉Extra Travel Grants for our in-person conferences for the rest of 2023.
We hope it makes some small difference.💔

[Özge Akbulut-Çalışkan @ozgeakblt]

@ozgursahin1905 Thank you very much for all that I learned from you hocam ^^

[Özge Akbulut-Çalışkan @ozgeakblt]

Very excited to share that I started a new position as Assistant Professor at Başkent University, Department of Molecular Biology and Genetics. 🎈

Many heartfelt thanks to all my mentors, friends and family ❣️
@baskent_mbg

[Özge Akbulut-Çalışkan @ozgeakblt]

🥳

[Moleküler Biyoloji Derneği @MolekulerD]

#doktorabasariodulu2021 #molekulerbiyolojidernegi

[Özgür Şahin @ozgursahin1905]

This is our new preprint! To get the latest updates and open positions, please follow our lab’s account @OzgurSahinLab

[Oncogene Journal @oncogenejournal]

In our latest issue @Erson_BensanLab, @ozgursahin1905 & co-workers show that SNX3 loss is linked to EGFR overexpression in triple-negative #BreastCancers.

👉https://t.co/dw6cjfSqpe #TNBC

[Erson-Bensan Lab METU @Erson_BensanLab]

EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers! Our latest work is now out @oncogenejournal.

[Caghan Kizil @CaKizil]

Bu süreçte yer yer o genetikçi virüs konuşmasın, eczacı laf etmesin, biyolog fikir bildirmesin vb dendi, hala da deniyor. Bunun neden yanlış bir argüman olduğunu yazayım.

[Clarivate for Life Sciences & Healthcare @ClarivateHealth]

The effect of TACC3 inhibition in blockage of mitotic progression highlights BO-264 as a promising anti-cancer agent to be developed for treatment of breast cancer. #ENA2018

[NatureRevClinOncol @NatRevClinOncol]

In multiple preclinical models, targeting lysyl oxidase, a hypoxia-induce ECM remodelling enzyme, overcomes chemotherapy resistance in triple-negative #breastcancer: https://t.co/ggEDPlAIC6 #bcsm

[Özge Akbulut-Çalışkan @ozgeakblt]

Glad to share our newest article published today in @NatureComms ^^

[Özgür Şahin @ozgursahin1905]

In our most recent article, we showed that targeting Lysyly oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer (TNBC), the most aggressive breast cancer subtype. Congrats to my current/former lab members and the collaborators.https://t.co/rLhPWQB3x0

[Bilkent UNAM @bilkentunam]

Bilkent UNAM'dan Serim İlday'ın liderliğini yaptığı, Ömer İlday, Özgür Şahin, H. Volkan Demir’in de yer aldığı çalışma alanının en saygın dergilerinden olan Nature Physics'de yayınlandı. https://t.co/w4FxevaQRO @ERC_Research @BilkentUniv @Tubitak

[Özge Akbulut-Çalışkan @ozgeakblt]

2020 meyveleri :)

[Nature Physics @NaturePhysics]

Universality of dissipative self-assembly from quantum dots to human cells https://t.co/gkVURv4jF6

[Özge Akbulut-Çalışkan @ozgeakblt]

Buyrun efenim bugün online olarak yayınlanan kansere karşı geliştirdiğimiz ilaç "adayıyla" ilgili olan ilk ilk-yazar makalem karşınızda. 🥳

Öncelikle hocam @ozgursahin1905'e ve sonrasında bütün katkısı olan yazarlara kocaman teşekkürler 🥰

https://t.co/QEsFCZJu8F

[Özgür Şahin @ozgursahin1905]

Türkiye’de ilaç geliştirilemez mi? Tabi ki geliştirilir! Ama ilaç geliştirmek uzun ve meşakkatli bir süreçtir. Tamamını Türkiye’de yaptığımız çalışmada kansere karşı geliştirdiğimiz ilaç ADAYInı bugün yayınladık. @erden_banoglu @ozgeakblt @uosseker https://t.co/8dXAoIrrXf